Research
The focus of the BADER Lab is utilization of bubble-based therapies to sensitize pathologies resistant to standard interventional approaches. Specifically, we develop and translate histotripsy technology, a focused ultrasound therapy that activates bubble nuclei intrinsic to the tissue targets. The resultant bubble activity can be utilized to ablate tissue, or enhance the delivery of drug agents.
![Bubble_Cloud](https://voices.uchicago.edu/baderlab/files/2020/06/Bubble_Cloud-1.gif)
Histotripsy-generated bubble cloud captured in real-time with a DSLR camera (Nikon D3400, Minato, Tokyo, Japan). The acoustic pulse propagates from the left to right in this video.
![](https://voices.uchicago.edu/baderlab/files/2020/06/Bubble_Cloud.gif)
![](https://voices.uchicago.edu/baderlab/files/2020/01/Picture1.jpg)
(Top panel) Representative histotripsy waveform. The tension of the pulse actives nanoscale bubble nuclei within the tissue.
(Bottom panel) Upon activation, the bubble diameter grows by a factor of 1,000 – 10,000, lysing nearby cells via mechanical strain.
Key References:
Kenneth B. Bader, Eli Vlaisavljevich, Adam D. Maxwell, “For whom the bubble grows: Histotripsy bubble dynamics,” Ultrasound in Medicine and Biology 45(5): 1056-1080, 2019. doi: 10.1060/j.ultrasmedbio.2018.10.035